drugset / Trial / NCT03982407
68 Ga PSMA PET/MRI for Hepatocellular Carcinoma
NaSingle-groupOpen-labelDiagnostic
Summary
This is a pilot study to investigate the evaluate to use of a drug/radiopharmaceutical called Gallium-68 PSMA-11 (68Ga-PSMA-11) for use in PET/MRI evaluation of hepatocellular carcinoma
Timeline
- Start
- 2019-06-27
- Primary completion
- 2021-05-05
- Completion
- 2022-04-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 68Ga-PSMA-11 | Diagnostic / imaging agent | — | — |